Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch

Updated on: August 27,2024 0

Study uncovers the role of NETO2-mediated regulation in melanoma progression

by Frontiers JournalsCredit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0935-0Cong Peng and others at the Department of Dermatology, Xiangya Hospital, Central South University, Ch

Updated on:August 27,2024 0

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on: January 04,2024 9

Change in breast density over time linked to cancer risk

by Tamara Bhandari,Washington University in St. LouisChange in Mammographic Density (MD) for the Case Breast in Case Patients and Control Participants Over Time. Credit:JAMA Oncology

Updated on:January 04,2024 9

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on: December 22,2023 17

Study examines causes of death in US breast cancer survivors

byWileyCredit: CC0 Public DomainSurvival rates for patients with breast cancer have improved significantly in the last four decades, and many patients will eventually die from non-cancer-related

Updated on:December 22,2023 17

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre

Updated on: December 21,2023 8

Multi-center study sheds light on understudied breast cancer type

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainA multi-center analysis of patients with invasive lobular carcinoma, or ILC—the second most common histological subtype of invasive bre

Updated on:December 21,2023 8

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea

Updated on: December 18,2023 11

Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce trea

Updated on:December 18,2023 11

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on: January 04,2024 5

FDA advisors to weigh new gene therapy for sickle cell anemia

by Cara MurezPatients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a newgene thera

Updated on:January 04,2024 5

Five cancers women must be vigilant about

byRoswell Park Cancer InstituteCredit: CC0 Public DomainWe asked some of Roswell Park's doctors who specialize in cancers that affect women to share some tips for preventing or treating canc

Updated on: December 18,2023 23

Five cancers women must be vigilant about

byRoswell Park Cancer InstituteCredit: CC0 Public DomainWe asked some of Roswell Park's doctors who specialize in cancers that affect women to share some tips for preventing or treating canc

Updated on:December 18,2023 23

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on: October 30,2023 22

New blood test revolutionizes early cancer detection in Li-Fraumeni Syndrome patients

In a study published inCancer Discovery, researchers from Canada tested the use of a multimodal liquid biopsy assay based on cell-free DNA (cfDNA) for early cancer detection in patients with Li-

Updated on:October 30,2023 22

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on: December 27,2023 6

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on:December 27,2023 6

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on: November 07,2023 6

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on:November 07,2023 6

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on: December 20,2023 10

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on:December 20,2023 10

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin

Updated on: December 19,2023 10

Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainWhile it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developin

Updated on:December 19,2023 10